Publication | Open Access

Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer

Activation DomainBreast OncologyOncogenic AgentMedicineBreast CancerTranscription Factor-2Cell BiologySystems BiologyCancer BiologyRadiation OncologyCell SignalingTumor Biology